Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Elevation Oncology
Seagen Inc.
Genmab
OncoNano Medicine, Inc.
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Medical University of South Carolina
Seagen Inc.
Seagen Inc.
Wake Forest University Health Sciences
Institut Bergonié
University of Miami
Eli Lilly and Company
Bagcilar Training and Research Hospital
University of Alabama at Birmingham
Stanford University
Memorial Sloan Kettering Cancer Center
INSYS Therapeutics Inc
Verastem, Inc.